Mutat Res 1997, 379:33–41.PubMedCrossRef 21. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, Niedzwiecki D, Compton C, Mayer RJ, Goldberg R, Bertagnolli MM, Boland CR: The CpG Island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 2007, 132:127–138.PubMedCrossRef
22. Leong KJ, Wei W, Tannahill LA, Caldwell GM, DihydrotestosteroneDHT molecular weight Jones CE, Morton DG, Matthews GM, Bach SP: Methylation profiling of rectal ��-Nicotinamide mouse Cancer identifies novel markers of early-stage disease. Br J Surg 2011, 98:724–734.PubMedCrossRef 23. Moon JW, Lee SK, Lee JO, Kim N, Lee YW, Kim SJ, Kang HJ, Kim J, Kim HS, Park SH: Identification of novel hypermethylated genes and demethylating effect of vincristine in colorectal cancer. J Exp Clin Cancer Res 2014, 33:4.PubMedCentralPubMed
24. Bardhan K, Liu K: Epigenetics and colorectal cancer pathogenesis. Cancers (Basel) 2013, 5:676–713.CrossRef 25. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, Kolodner R: Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997, 57:808–811.PubMed 26. Fu D, Calvo JA, Samson LD: Balancing repair and tolerance of DNA damage caused by alkylating agents. Nat Rev Cancer 2012, 12:104–120.PubMedCentralPubMed 27. Lavin MF: Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling Smoothened and cancer. Nat Rev Mol Cell Biol 2008, 9:759–769.PubMedCrossRef 28. Shiloh Y: ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer HM781-36B 2003, 3:155–168.PubMedCrossRef 29. Huebner K, Saldivar JC, Sun J, Shibata H, Druck T: Hits, Fhits and Nits: beyond enzymatic function. Adv Enzyme Regul 2011, 51:208–217.PubMedCentralPubMedCrossRef 30. Wali A: FHIT: doubts are clear now. Scientific World Journal 2010, 10:1142–1151.PubMedCrossRef 31. Al-Temaimi RA, Jacob S, Al-Ali W, Thomas DA, Al-Mulla F: Reduced FHIT expression is associated
with mismatch repair deficient and high CpG island methylator phenotype colorectal cancer. J Histochem Cytochem 2013, 61:627–638.PubMedCrossRef 32. Portela A, Esteller M: Epigenetic modifications and human disease. Nat Biotechnol 2010, 28:1057–1068.PubMedCrossRef 33. Herreros-Villanueva M, Muñiz P, García-Girón C, Cavia-Saiz M, Del Corral MJ: TAp73 is one of the genes responsible for the lack of response to chemotherapy depending on B-Raf mutational status. J Transl Med 2010, 8:15.PubMedCentralPubMedCrossRef 34. Allocati N, Di Ilio C, De Laurenzi V: p63/p73 in the control of cell cycle and cell death. Exp Cell Res 2012, 318:1285–1290.PubMedCrossRef 35. Murphy CG, Moynahan ME: BRCA gene structure and function in tumor suppression: a repair-centric perspective. Cancer J 2010, 16:39–47.PubMedCrossRef 36.